Clinical Trial Update: Clinical Effectiveness and Safety of Trastuzumab Deruxtecan (T-DXd) in Chinese Patients With HER2m NSCLC (RERUN)

View source ↗

Summary

This clinical trial update indicates ongoing recruitment to evaluate the effectiveness and safety of Trastuzumab deruxtecan (T-DXd) in Chinese patients with HER…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Trastuzumab deruxtecan (trastuzumab deruxtecan)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Non-small Cell Lung Cancer | Status: RECRUITING